BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mazzoccoli G, Tarquini R, Valoriani A, Oben J, Vinciguerra M, Marra F. Management strategies for hepatocellular carcinoma: old certainties and new realities. Clin Exp Med 2016;16:243-56. [PMID: 26077653 DOI: 10.1007/s10238-015-0368-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Carbone A, De Santis E, Cela O, Giambra V, Miele L, Marrone G, Grieco A, Buschbeck M, Capitanio N, Mazza T, Mazzoccoli G. The Histone Variant MacroH2A1 Impacts Circadian Gene Expression and Cell Phenotype in an In Vitro Model of Hepatocellular Carcinoma. Biomedicines 2021;9:1057. [PMID: 34440260 DOI: 10.3390/biomedicines9081057] [Reference Citation Analysis]
2 Deng G, Luo Y, Zhang Y, Zhang J, He Z. Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathway. Bioengineered 2022;13:2194-206. [PMID: 35030977 DOI: 10.1080/21655979.2021.2023983] [Reference Citation Analysis]
3 Verger E, Drion P, Meffre G, Bernard C, Duwez L, Lepareur N, Couturier O, Hindré F, Hustinx R, Lacoeuille F. 68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies. PLoS One 2016;11:e0164626. [PMID: 27741267 DOI: 10.1371/journal.pone.0164626] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
4 Chen X, Zhang Q, Ma W, Lan T, Hong Z, Yuan Y. The Abnormal Expression of MicroRNA-542-3p in Hepatocellular Carcinoma and Its Clinical Significance. Dis Markers 2018;2018:3973250. [PMID: 29606985 DOI: 10.1155/2018/3973250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Lo Re O, Panebianco C, Porto S, Cervi C, Rappa F, Di Biase S, Caraglia M, Pazienza V, Vinciguerra M. Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells. J Cell Physiol 2018;233:1202-12. [PMID: 28471474 DOI: 10.1002/jcp.25987] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
6 Liu Y, Deng H, Liang L, Zhang G, Xia J, Ding K, Tang N, Wang K. Depletion of VPS35 attenuates metastasis of hepatocellular carcinoma by restraining the Wnt/PCP signaling pathway. Genes Dis 2021;8:232-40. [PMID: 33997170 DOI: 10.1016/j.gendis.2020.07.009] [Reference Citation Analysis]
7 Ding H, Liu J, Liu B, Zeng Y, Chen P, Su Y. Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1. Biochem Biophys Res Commun 2018;500:973-80. [PMID: 29715456 DOI: 10.1016/j.bbrc.2018.04.219] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
8 Liu J, Fan L, Yu H, Zhang J, He Y, Feng D, Wang F, Li X, Liu Q, Li Y, Guo Z, Gao B, Wei W, Wang H, Sun G. Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate Programmed Death Ligand 1 Expression in Macrophages. Hepatology 2019;70:241-58. [PMID: 30854665 DOI: 10.1002/hep.30607] [Cited by in Crossref: 52] [Cited by in F6Publishing: 93] [Article Influence: 17.3] [Reference Citation Analysis]
9 Li BH, Wang Y, Wang CY, Zhao MJ, Deng T, Ren XQ. Up-Regulation of Phosphatase in Regenerating Liver-3 (PRL-3) Contributes to Malignant Progression of Hepatocellular Carcinoma by Activating Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN)/Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway. Med Sci Monit 2018;24:8105-14. [PMID: 30418964 DOI: 10.12659/MSM.913307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Dong Y, Wang Q, Sun J, Liu H, Wang H. Long non-coding RNA TPTEP1 exerts inhibitory effects on hepatocellular carcinoma by impairing microRNA-454-3p-mediated DLG5 downregulation. Dig Liver Dis 2021:S1590-8658(21)00199-7. [PMID: 34238665 DOI: 10.1016/j.dld.2021.04.014] [Reference Citation Analysis]
11 Liu Y, Gao F, Song W. Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia. Biomed Pharmacother 2017;88:342-8. [PMID: 28119236 DOI: 10.1016/j.biopha.2017.01.052] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
12 Cao C, Wang C. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism. Clin Exp Med 2020;20:569-76. [PMID: 32712720 DOI: 10.1007/s10238-020-00646-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wu L, Chen P, Ying J, Zhang Q, Liu F, Lv B, Che Z, Zhang W, Wu M, Zhang J, Yang D, Liu J. MAT2B mediates invasion and metastasis by regulating EGFR signaling pathway in hepatocellular carcinoma. Clin Exp Med 2019;19:535-46. [PMID: 31493275 DOI: 10.1007/s10238-019-00579-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhengjie S, Wenzhe G, Haibo C, Weixing S, Dongdong S, Yun Z, Lihuiping T, Mianhua W. Effect of Aidi injection plus transarterial chemoembolization on primary hepatic carcinoma: a systematic review and Meta-analysis. Journal of Traditional Chinese Medicine 2017;37:567-87. [DOI: 10.1016/s0254-6272(17)30310-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
15 Chang Lee R, Tebbutt N. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon. Expert Rev Anticancer Ther 2019;19:343-53. [PMID: 30793991 DOI: 10.1080/14737140.2019.1585245] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Chen J, Huang C, Chen K, Li S, Zhang X, Cheng J, Cai M, Xiao Y. Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma. Onco Targets Ther 2018;11:441-8. [PMID: 29403288 DOI: 10.2147/OTT.S152953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
17 Song Y, Jin X, Liu Y, Wang S, Bian F, Zhao Q, Shi H, Gao Z. Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p/HIF-1α axis. Anticancer Drugs 2021;32:812-21. [PMID: 34102651 DOI: 10.1097/CAD.0000000000001070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Korkusuz H, Wolf T, Grünwald F. Feasibility of bipolar radiofrequency ablation in patients with parathyroid adenoma: a first evaluation. International Journal of Hyperthermia 2018;34:639-43. [DOI: 10.1080/02656736.2018.1453552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
19 Peng C, Zhang Z, Liu J, Chen H, Tu X, Hu R, Ni J, Weng N, Pang H, Xue Z. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease. Head Neck 2017;39:564-71. [PMID: 28032671 DOI: 10.1002/hed.24657] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]